The family of a fanatical Stoke City supporter and long-serving former police officer have paid tribute after he lost his ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

New Delhi: Reviewing the Phase III clinical trial protocol of the GZ402671 (Venglustat) presented by the pharma major Sanofi, ...

Neumora Therapeutics, Inc. (NMRA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

This form of CED drug delivery is currently being used in clinical trials to treat a range of neurological conditions, ...

Varenicline is a once-a-day pill to help smokers quit and will be available for free on NHS prescription to those who are ...

"Smoking can reduce brain volume," says Dr Steven Allder, consultant neurologist at Re:Cognition Health. "Studies show that ...

CED drug delivery is currently being used in clinical trials to treat a range of neurological conditions, including Parkinson ...

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, ...

Autism · ADHD · Schizophrenia · Stroke · Brain Tumors · Multiple Sclerosis · Parkinson’s Disease · Epilepsy and Seizures · Dyslexia · Dementia · Cerebral Aneurysm We encourage submissions that explore ...

Understanding this form of dementia is a step towards offering the compassion and support that those affected truly deserve.